Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Ulrichts

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|September 28, 2007
Inhibition of platelet glycoprotein Ib and its antithrombotic potentialKaren Vanhoorelbeke, Hans Ulrichts, Gerlinde Van de Walle, et al.
Trends in Molecular Medicine|January 15, 2004
The GPIbalpha-thrombin interaction: far from crystal clearKaren Vanhoorelbeke, Hans Ulrichts, Roland A Romijn, et al.
Thrombosis and Haemostasis|December 2, 2006
Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIbaLuca Pontiggia, Beat Steiner, Hans Ulrichts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 31, 2003
von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphismHans Ulrichts, Karen Vanhoorelbeke, Sandra Cauwenberghs, et al.
Blood|April 17, 2013
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigsStefania Momi, Michela Tantucci, Maarten Van Roy, et al.
Transfusion|December 21, 2006
Role of glycoprotein Ibalpha in phagocytosis of platelets by macrophagesBahram A Badlou, Gerrit Spierenburg, Hans Ulrichts, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 22, 2005
How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?Gufeng Xu, Hans Ulrichts, Stephan Vauterin, et al.
The Journal of Biological Chemistry|December 24, 2005
Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-VHans Ulrichts, Miklós Udvardy, Peter J Lenting, et al.
The Journal of Biological Chemistry|October 7, 2004
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sitesChristelle Lecut, Véronique Arocas, Hans Ulrichts, et al.
Bioanalysis|October 7, 2020
Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practiceJoanne Goodman, Kyra J Cowan, Michaela Golob, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|September 28, 2007
Inhibition of platelet glycoprotein Ib and its antithrombotic potentialKaren Vanhoorelbeke, Hans Ulrichts, Gerlinde Van de Walle, et al.
Trends in Molecular Medicine|January 15, 2004
The GPIbalpha-thrombin interaction: far from crystal clearKaren Vanhoorelbeke, Hans Ulrichts, Roland A Romijn, et al.
Thrombosis and Haemostasis|December 2, 2006
Platelet microparticle formation and thrombin generation under high shear are effectively suppressed by a monoclonal antibody against GPIbaLuca Pontiggia, Beat Steiner, Hans Ulrichts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 31, 2003
von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphismHans Ulrichts, Karen Vanhoorelbeke, Sandra Cauwenberghs, et al.
Blood|April 17, 2013
Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigsStefania Momi, Michela Tantucci, Maarten Van Roy, et al.
Transfusion|December 21, 2006
Role of glycoprotein Ibalpha in phagocytosis of platelets by macrophagesBahram A Badlou, Gerrit Spierenburg, Hans Ulrichts, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 22, 2005
How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?Gufeng Xu, Hans Ulrichts, Stephan Vauterin, et al.
The Journal of Biological Chemistry|December 24, 2005
Shielding of the A1 domain by the D'D3 domains of von Willebrand factor modulates its interaction with platelet glycoprotein Ib-IX-VHans Ulrichts, Miklós Udvardy, Peter J Lenting, et al.
The Journal of Biological Chemistry|October 7, 2004
Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sitesChristelle Lecut, Véronique Arocas, Hans Ulrichts, et al.
Bioanalysis|October 7, 2020
Update to the European Bioanalysis Forum recommendation on biomarkers assays; bringing context of use into practiceJoanne Goodman, Kyra J Cowan, Michaela Golob, et al.
Pageof 2